Founding Partner
The U.S. Food and Drug Administration has announced a nationwide recall involving certain packages of Gas-X, a widely used over-the-counter medication commonly taken for gas and bloating relief. According to federal regulators, more than 285,000 blister cards of the product have been affected by a labeling error involving incomplete inactive ingredient disclosures.
The recall has drawn national attention because Gas-X is a product found in medicine cabinets across the country and is routinely used by consumers seeking relief from digestive discomfort. Although the FDA classified the recall as a Class II event, meaning exposure is not likely to cause permanent health consequences, regulators stated that the issue could still lead to temporary or medically reversible adverse effects in some individuals.
Consumers often rely heavily on product labels when selecting medications, particularly those who have allergies, sensitivities, dietary restrictions, or medical conditions requiring close review of ingredients. Even inactive ingredients can present concerns for certain individuals depending on their medical history, sensitivities, or interactions.
The recall affects specific packages of Gas-X distributed by Haleon US Holdings LLC. The issue reportedly involves incomplete inactive ingredient lists printed on product labeling. While the medication’s active ingredient remains simethicone 125 mg, the inaccurate labeling raises questions regarding consumer safety, product oversight, and whether individuals were deprived of information necessary to make informed health decisions.
Federal agencies continue to emphasize the importance of accurate pharmaceutical labeling because consumers, physicians, and caregivers use this information to evaluate risks before taking medication. When labeling errors occur involving medications sold on a nationwide scale, the consequences can potentially impact thousands of households.
The FDA identified specific recalled Gas-X products using lot codes, expiration dates, and packaging details. Consumers who purchased Gas-X products should carefully inspect their medication packaging to determine whether they possess an affected product.
According to recall information released by regulators, the recalled product includes:
The recall reportedly began on May 11, while the FDA later classified the recall as Class II on May 19. Consumers nationwide may have purchased these products through pharmacies, grocery stores, warehouse retailers, online sellers, and other retail outlets.
Because the recalled medication has a long shelf life extending into 2028, affected products may remain in homes for years if consumers are unaware of the recall notice.
Some consumers may question why an incomplete inactive ingredient list would trigger a nationwide recall. Pharmaceutical labeling serves a critical medical and safety function. Consumers use ingredient disclosures to identify substances that may trigger allergic reactions, digestive problems, sensitivities, or other adverse health effects.
Inactive ingredients are not medically “inactive” for every person. Certain individuals may react negatively to dyes, preservatives, fillers, flavorings, stabilizers, or coating materials commonly used in medications. Consumers with allergies or chemical sensitivities often review labels carefully before purchasing or taking over-the-counter medications.
Potential risks associated with incomplete labeling may include:
Accurate labeling also allows healthcare providers to evaluate whether a medication may contribute to symptoms or complications experienced by a patient. If ingredient information is incomplete, diagnosis and treatment decisions may become more complicated.
Federal regulations governing pharmaceutical labeling exist because consumers have the right to understand what substances they are putting into their bodies. When critical information is omitted, even unintentionally, consumers may unknowingly expose themselves to avoidable risks.
The FDA assigned the Gas-X recall a Class II designation. This category indicates that use of the affected product may cause temporary or medically reversible health consequences, but that serious permanent injuries are less likely.
FDA recall classifications generally fall into three categories:
Although Class II recalls are considered less severe than Class I events, they still represent important public health concerns. The FDA does not issue nationwide recall classifications lightly. A Class II designation means regulators determined there is a meaningful possibility that consumers could experience health effects from the product issue.
Consumers should not assume that a Class II recall means the product is completely safe. Instead, it means regulators identified sufficient risk to warrant removal of the affected products from circulation.
Consumers place enormous trust in over-the-counter medications. Millions of Americans rely on nonprescription products every day for relief from pain, allergies, digestive problems, cold symptoms, and other common conditions.
When consumers purchase a medication from a pharmacy shelf, they reasonably expect:
A labeling issue affecting hundreds of thousands of medication packages may raise broader questions regarding manufacturing oversight, packaging review procedures, and quality assurance protocols.
Large-scale recalls can also undermine consumer confidence, particularly when they involve products frequently used by families, older adults, or individuals managing chronic health concerns.
The FDA did not provide extensive consumer instructions beyond identifying the recall. However, because the products contain incomplete labeling information, many consumers may choose to stop using the recalled medication immediately.
Consumers who possess affected Gas-X products should consider:
Consumers experiencing adverse effects after using recalled medications may also consider filing reports with the FDA’s MedWatch adverse event reporting system.
Drug recalls sometimes lead to legal claims when consumers suffer injuries, allergic reactions, or other complications linked to pharmaceutical defects, labeling failures, or manufacturing problems.
Depending on the circumstances, legal claims involving recalled medications may include:
Individuals harmed by recalled medications may seek compensation for:
Medication-related litigation often involves detailed investigations into internal quality control procedures, labeling review processes, regulatory compliance, and company knowledge regarding potential risks.
Medication recalls often receive widespread attention because pharmaceutical products are deeply integrated into daily life. Consumers trust that medications sold nationwide comply with strict federal safety requirements.
When recalls involve labeling issues, contamination concerns, dosage inaccuracies, or undisclosed ingredients, the public naturally becomes concerned about product safety standards and oversight practices.
Drug recalls may also disproportionately affect:
Even when regulators describe risks as temporary or reversible, recalls can create confusion, anxiety, and financial burdens for affected consumers.
Can consumers file a lawsuit over a recalled medication?
Possibly. Whether a person has a legal claim depends on the facts of the situation, including whether the recalled product caused injuries, allergic reactions, financial losses, or other damages. Medication recalls involving labeling errors may lead to claims if consumers were harmed because they lacked important safety information.
Why do inactive ingredient labels matter?
Inactive ingredients can still affect consumers in significant ways. Some people have allergies or sensitivities to dyes, preservatives, fillers, or coating materials used in medications. Accurate labeling allows consumers and healthcare providers to make informed medical decisions and avoid ingredients that may trigger harmful reactions.
What should consumers do if they already used recalled Gas-X?
Consumers who used recalled products should monitor for unusual symptoms or adverse reactions. If health problems develop, medical attention may be necessary. Individuals should also preserve the product packaging, receipt, and lot information whenever possible in case additional investigation becomes necessary.
What is a Class II recall?
A Class II recall means the FDA believes exposure to the product could cause temporary or medically reversible health problems. Although these recalls are considered less severe than Class I recalls, they still involve products that regulators determined may pose meaningful risks to consumers.
Can consumers recover compensation after injuries caused by recalled medications?
Potential compensation depends on the circumstances and severity of harm involved. Individuals may seek recovery for medical bills, lost income, pain and suffering, and other losses connected to injuries caused by recalled pharmaceutical products.
Consumers trust medication labels to provide accurate and complete safety information. When pharmaceutical products allegedly contain labeling errors that may place consumers at risk, families deserve answers.
Parker Waichman LLP represents individuals nationwide in product liability and dangerous drug litigation involving recalled consumer products and medications.
If you or a loved one experienced complications, allergic reactions, or other health problems after using recalled Gas-X products, Parker Waichman LLP can evaluate your potential claim during a free consultation.
Call 1-800-YOUR-LAWYER (1-800-968-7529) today to learn more about your legal rights. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
We handle mass torts cases nationwide. Please contact our office to learn more.